We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies . More info . X close

In Vitro Toxicology Testing Market: Growth, Size, Share, and Trends

Report Code BT 2373
Published in Oct, 2023, By MarketsandMarkets™
Download PDF

Choose License Type

Buy Report Now Inquire Before Buying

In Vitro Toxicology Testing Market by Product & Service (Assays (ELISA & Western Blot), Equipment, Consumable, Software), Toxicity Endpoints (ADME, Genotoxicity, Cytotoxicity), Technology, Method, Industry (Pharma, Cosmetics) - Global Forecast to 2028

Overview

The global in vitro toxicology testing market, valued at US$10.1 billion in 2022, is forecasted to grow at a robust CAGR of 9.5%, reaching US$10.8 billion in 2023 and an impressive US$17.1 billion by 2028. This remarkable expansion is fueled by the advent of cutting-edge toxicology testing technologies and heightened investment in research and development for early toxicity detection. The market's growth trajectory is further propelled by its alignment with stringent regulations banning animal testing, leading to significant industry expansion over the past decade.

Attractive Opportunities in the In Vitro Toxicology Testing Market

ASIA PACIFIC:

The growth of the Asia Pacific in vitro toxicology market is primarily due to the growing biopharmaceutical industry, increasing life science research, and rise of CROs specializing in outsourcing toxicology-related research projects in the region

Growth in this market is primarily driven by the increasing adoption of in vitro testing and increasing research and development efforts aimed at early toxicity detection.

Lack of in vitro models to study complex end points restraining the market growth.

Robust growth in the pharmaceutical industry, and surge in the consumer awareness about product safety driving the demand of in vitro toxicology testing market

The Asia Pacific market is estimated to grow at the highest CAGR during the forecast period.

Global In Vitro Toxicology Testing Market Dynamics

DRIVER: Growing public resistance against animal testing

The increasing resistance of the public towards animal testing has been a significant driving force for the growth of the in vitro toxicology testing market. This shift in public sentiment is driven by various factors, including ethical concerns, awareness of animal rights, and a growing understanding of the limitations and ethical dilemmas associated with traditional animal testing methods. As a result, there has been a notable impetus to find alternative approaches to assess the safety and toxicity of products and substances without relying on animal experimentation. Animal testing is a highly time-consuming process and involves high costs and immense safety risks for the animals involved. Working with rodent and rabbit models also increases the risk of zoonotic diseases. The European Animal Research Association, 7th Amendment to EU Directive 76/768/EEC, passed in 2003, introduced a gradual prohibition on animal testing for cosmetics, culminating in a deadline of 2013. On March 11, 2013, the complete ban took effect, making it unlawful to market or sell cosmetics within the EU if either the finished product or its constituent ingredients had undergone testing on animals.

RESTRAINT: Failure to establish intricacies of in vivo conditions

With regulatory authorities introducing bans on animal testing in several countries for testing drugs or substances with potential hazards, in vitro toxicity testing is gaining wide recognition. However, compared to in vivo tests, in vitro toxicology testing methods still need to demonstrate their validity. In vitro tests can determine only the mechanism of action of test substances and not their outcomes after being metabolized. A chemical substance may not be harmful, but its metabolites can prove to be detrimental. One such example is a polycyclic aromatic hydrocarbon (PAH), benzo[a]pyrene, a metabolite of a chemical that is mutagenic and carcinogenic. In vivo methods are still practiced in the pharmaceuticals, food, and chemical industries to ensure the safety of substances. Research in the workings of in vivo environments is still lacking; as a result, while efforts are being made to develop in vitro techniques to simulate in vivo conditions, there are no tangible results yet. Hence, the use of in vivo methods is the major restraint of this market.

 

OPPORTUNITY: Increasing focus on predictive toxicology

Predictive toxicology relies on structure-activity relationship (SAR) modeling to predict biological activities in chemical structures. Such approaches have proven capabilities when applied to well-defined toxicity endpoints or regions of chemical space. Computational approaches continue to increase in capability and applicability to predictive toxicology. These advanced methodologies are utilized in various stages of the development of substances by predicting properties that correlate with toxicity endpoints, structure-activity relationship models for new chemical formulations, and building/retrieving information on chemical databases. In the field of drug design, one primary need is the early recognition of potentially toxic molecules. In fact, attrition due to nonclinical safety represents a major issue for the productivity of pharmaceutical R&D. To this end, the development of predictive toxicology assays and models has become a primary concern for drugmakers.

CHALLENGE: Complexity in data analysis and management

Complexity in data analysis and management has emerged as a major limitation to the growth of the in vitro toxicology testing market. One key factor is the sheer volume of data generated during in vitro toxicology experiments. With the advent of high-throughput screening technologies, researchers can assess thousands of compounds simultaneously, leading to massive datasets. Managing and analyzing this data requires advanced computational tools and expertise, which can be expensive and timeconsuming to develop and maintain. For example, a pharmaceutical company conducting toxicity screening for a new drug candidate may generate terabytes of data from various assays, making it challenging to extract meaningful insights efficiently. Moreover, the diversity of data types in in vitro toxicology adds to the complexity. Researchers integrate information from genomics, proteomics, metabolomics, and other omics disciplines to gain a comprehensive understanding of toxicity mechanisms. This multidimensional data landscape demands sophisticated data integration and analysis approaches, which can be a barrier for smaller companies and research institutes with limited resources.

Global In Vitro Toxicology Testing Market Ecosystem Analysis

The ecosystem of in vitro toxicology testing consists of end users from pharmaceutical & biotechnology companies, consumer care companies, food industry, chemical industry, and academic & research institutes, in vitro toxicology testing product and service providers, instrument & reagent suppliers, technology providers, data management & analysis providers, regulatory authorities (ensuring compliance and safety), and collaborative networks promoting knowledge sharing and collaboration. These stakeholders interact and collaborate to drive the advancement of in vitro toxicology testing products and services, enhance drug discovery processes, and develop new therapeutics.

 

Cellular assays held a dominant share in the method segment in the in vitro toxicology testing industry

Based on the method, the in vitro toxicology testing market has been segmented into cellular assays, biochemical assays, molecular toxicology assays, ex vivo models, and in silico models. In 2022, cellular assays accounted for the largest share of the in vitro toxicology testing market. This is attributed to the high adoption of these assays across all industries due to their higher speed, higher efficiency, and lower cost than other methods.

The toxicogenomics segment of the in vitro toxicology testing industry is expected to register fastest growth during the forecast period.

Based on the technologies used in in vitro toxicology testing, the market has been segmented into cell culture, high-throughput screening, and toxicogenomics. In 2022, cell culture technologies accounted for the largest share. The cell culture technology segment's dominance is due to its status as the preferred method for toxicity testing because of its ability to replicate in vivo conditions. Nonetheless, it is anticipated that the toxicogenomics segment will achieve the highest CAGR during the projected period. The advancement of technology in proteomics and genomics is predicted to support the expansion of this segment.

EUROPE Region Holds the Largest Share of the In Vitro Toxicology Testing Market

Geographically, the In vitro toxicology testing market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. Europe held the dominant share followed by North America. The European Union has been a leader in supporting research for the development and validation of advanced in vitro toxicology testing protocols for regulatory purposes. Thus, the development of newer drugs and personal care products, R&D efforts by EU states to bring in alternatives to animal testing, and a ban on animal-tested cosmetics are contributing to the growth of the European in vitro toxicology testing market.

Recent Developments of In Vitro Toxicology Testing Market industry

  • In March 2023, Agilent Technologies, Inc. (US) acquired e-MSion (US). Through this acquisition, Agilent will integrate the e-MSion’s ExD cell into its portfolio of advanced workflows, instruments, and analytical solutions for biotherapeutic characterization and development.
  • In January 2023, Eurofins Scientific expanded its presence in India with the establishment of a new, fully equipped, state-of-the-art laboratory campus in Genome Valley, Hyderabad. The lab will support pharma and biotech companies in the areas of synthetic organic chemistry, analytical R&D, bioanalytical services, in vivo pharmacology, safety toxicology, and formulation R&D.

Key Market Players

KEY PLAYERS IN THE In Vitro Toxicology Testing Market INCLUDE

Want to explore hidden markets that can drive new revenue in In Vitro Toxicology Testing Market?

Scope of the Report

Report Attribute Details
Market Revenue in 2023 $10.8 billion
Estimated Value by 2028 $17.1 billion
Revenue Rate Poised to grow at a CAGR of 9.5%
Market Driver Growing public resistance against animal testing
Market Opportunity Increasing focus on predictive toxicology

Key Questions Addressed by the Report

What is the projected growth rate of the global in vitro toxicology testing market between 2023 and 2028?
The global in vitro toxicology testing market is expected to grow from USD 10.8 billion in 2023 to USD 17.1 billion by 2028, with a compound annual growth rate (CAGR) of 9.5%. This growth is driven by increasing demand for alternative toxicology testing methods and advancements in predictive toxicology technologies.
What are the key drivers of the in vitro toxicology testing market?
The primary drivers of the in vitro toxicology testing market include growing public opposition to animal testing, advancements in alternative testing technologies, and regulatory restrictions banning animal testing, especially in the cosmetics and pharmaceutical industries.
What are the major challenges in the in vitro toxicology testing market?
One of the major challenges in the in vitro toxicology testing market is the difficulty in replicating the complexities of in vivo conditions, making it challenging to fully establish the validity of in vitro methods for certain toxicity endpoints.
Which regions are expected to lead the in vitro toxicology testing market?
Europe is expected to hold the largest share of the in vitro toxicology testing market, followed by North America. Europe’s dominance is driven by strict regulations banning animal testing and extensive investments in research and development for alternative testing methods.
What role does predictive toxicology play in the market?
Predictive toxicology is becoming increasingly important in the market as it allows researchers to use computational models to predict toxicological outcomes. These models help identify toxic substances earlier in the drug development process, improving efficiency and reducing reliance on animal testing.
What advancements are driving the growth of in vitro toxicology testing?
Advancements in high-throughput screening, cell culture technologies, and toxicogenomics are major contributors to the growth of in vitro toxicology testing. These innovations allow faster, more accurate, and cost-effective testing solutions compared to traditional methods.
How does the public resistance to animal testing impact the market?
The growing public resistance to animal testing, driven by ethical concerns and regulatory bans, is significantly boosting the adoption of in vitro toxicology testing. This shift has encouraged the development of alternative testing methods that do not rely on animals.
Which industries are adopting in vitro toxicology testing?
In vitro toxicology testing is widely adopted across several industries, including pharmaceuticals, biotechnology, cosmetics, chemicals, and consumer care products. The push for safer products and stricter regulations are driving adoption in these sectors.
What are the recent developments in the in vitro toxicology testing market?
Recent developments include Agilent Technologies’ acquisition of e-MSion to enhance its biotherapeutic characterization capabilities and Eurofins Scientific’s expansion in India, further strengthening its global toxicology testing services.
What are the main challenges in data analysis for in vitro toxicology testing?
One of the main challenges in data analysis for in vitro toxicology testing is managing the vast volume of data generated from high-throughput screening. Integrating and analyzing complex data from multiple sources requires sophisticated tools and expertise, posing challenges for smaller companies and research institutions.

 

Adjacent Markets

Request Bundle Reports

Personalize This Research

  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
Request A Free Customisation

Let Us Help You

  • What are the Known and Unknown Adjacencies Impacting the In Vitro Toxicology Testing Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
Customized Workshop Request

Table of Contents

Exclusive indicates content/data unique to MarketsandMarkets and not available with any competitors.

TITLE
PAGE NO
INTRODUCTION
32
RESEARCH METHODOLOGY
38
EXECUTIVE SUMMARY
51
PREMIUM INSIGHTS
56
MARKET OVERVIEW
59
  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    MARKET DRIVERS
    - Growing public resistance against animal testing
    - Technological advancements
    - Research and development efforts aimed at early-stage toxicity detection
    MARKET RESTRAINTS
    - Resistance of certain regulatory bodies to embrace alternative approaches in toxicology testing
    - Failure to establish intricacies of in vivo conditions
    - Lack of in vitro models to study complex endpoints
    MARKET OPPORTUNITIES
    - Growing focus on drug discovery and personalized medicine using in vitro methods
    - Increasing number of toxicology databases
    - Increasing focus on predictive toxicology
    MARKET CHALLENGES
    - Lack of data availability and validation
    - Complexity in data analysis and management
  • 5.3 TRENDS/DISRUPTIONS IMPACTING CUSTOMER’S BUSINESS
  • 5.4 PRICING ANALYSIS
    AVERAGE SELLING PRICE OF IN VITRO TOXICOLOGY TESTING PRODUCTS, BY KEY PLAYER, 2022
    AVERAGE SELLING PRICE OF IN VITRO TOXICOLOGY TESTING PRODUCTS, BY REGION, 2022
    AVERAGE SELLING PRICE TREND
  • 5.5 VALUE CHAIN ANALYSIS
  • 5.6 SUPPLY CHAIN ANALYSIS
  • 5.7 ECOSYSTEM ANALYSIS
  • 5.8 PATENT ANALYSIS
  • 5.9 TECHNOLOGY ANALYSIS
  • 5.10 KEY CONFERENCES & EVENTS, 2023–2024
  • 5.11 REGULATORY LANDSCAPE
    REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    REGULATORY SCENARIO
  • 5.12 PORTER’S FIVE FORCES ANALYSIS
    THREAT OF NEW ENTRANTS
    THREAT OF SUBSTITUTES
    BARGAINING POWER OF SUPPLIERS
    BARGAINING POWER OF BUYERS
    INTENSITY OF COMPETITIVE RIVALRY
  • 5.13 KEY STAKEHOLDERS & BUYING CRITERIA
    KEY STAKEHOLDERS IN BUYING PROCESS
    BUYING CRITERIA FOR IN VITRO TOXICITY TESTING
IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE
89
  • 6.1 INTRODUCTION
  • 6.2 CONSUMABLES
    INCREASING DEMAND FOR HIGH-QUALITY REAGENTS TO DRIVE MARKET
  • 6.3 ASSAYS
    BACTERIAL TOXICITY ASSAYS
    - High sample throughput and rapid response to toxicants to drive adoption
    ENZYME TOXICITY ASSAYS
    - Increasingly used in endocrine-disrupting studies
    CELL-BASED ELISA & WESTERN BLOTTING ASSAYS
    - Simple, fast, and cost-effective alternatives to large-scale and cost-intensive animal testing
    RECEPTOR-BINDING ASSAYS
    - Suitable for high-throughput formats
    TISSUE CULTURE ASSAYS
    - Increasing cost of animal studies to propel market
    OTHER ASSAYS
  • 6.4 SERVICES
    LACK OF INFRASTRUCTURE AND EXPERTISE IN RESEARCH CENTERS TO SUPPORT MARKET GROWTH
  • 6.5 EQUIPMENT
    ADOPTION OF ADVANCED TESTING EQUIPMENT TO MEET NEW REGULATORY STANDARDS TO PROPEL MARKET
  • 6.6 SOFTWARE
    CRUCIAL ROLE IN DECREASING ANALYSIS TIME AND EFFECTIVELY HANDLING SUBSTANTIAL DATA VOLUMES
IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICITY ENDPOINT & TEST
124
  • 7.1 INTRODUCTION
  • 7.2 ABSORPTION, DISTRIBUTION, METABOLISM, & EXCRETION
    PRODUCES HIGHLY REPRODUCIBLE & ACCURATE DATA
  • 7.3 GENOTOXICITY
    RIGOROUS REGULATORY REQUIREMENTS FOR NEW DRUGS TO AID MARKET GROWTH
  • 7.4 SKIN IRRITATION, CORROSION, & SENSITIZATION
    MAJOR ENDPOINTS STUDIED IN COSMETICS INDUSTRY
  • 7.5 CYTOTOXICITY
    RISING NEED FOR BIOSAFETY TO SUPPORT MARKET GROWTH
  • 7.6 OCULAR TOXICITY
    IN VITRO AND EX VIVO TECHNIQUES INCREASINGLY GAINING ATTENTION FOR EVALUATION OF OCULAR TOXICITY
  • 7.7 ORGAN TOXICITY
    FASTEST-GROWING SEGMENT OF MARKET
  • 7.8 DERMAL TOXICITY
    ONGOING GOVERNMENT INITIATIVES AND CHANGES IN REGULATORY GUIDELINES TO SUPPORT MARKET GROWTH
  • 7.9 PHOTOTOXICITY
    ESTABLISHED NON-ANIMAL TECHNIQUES EMPLOYED TO ASSESS PHOTOTOXICITY OF COSMETICS, PHARMACEUTICALS, AND CHEMICALS
  • 7.10 OTHER ENDPOINTS & TESTS
IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY
152
  • 8.1 INTRODUCTION
  • 8.2 PHARMACEUTICAL & BIOPHARMACEUTICAL
    GROWING R&D EXPENDITURE TO FAVOR MARKET GROWTH
  • 8.3 CONSUMER CARE
    GROWING DEMAND FOR CRUELTY-FREE COSMETICS AND PERSONAL CARE PRODUCTS TO DRIVE MARKET
  • 8.4 FOOD
    INCREASING FOCUS ON FOOD SAFETY TO PROPEL MARKET
  • 8.5 OTHER INDUSTRIES
IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY
168
  • 9.1 INTRODUCTION
  • 9.2 CELL CULTURE
    MOST PREFERRED TECHNIQUE FOR TOXICITY TESTING
  • 9.3 HIGH-THROUGHPUT SCREENING
    INCREASING USE OF HIGH-CONTENT IMAGING TECHNOLOGIES IN TOXICITY TESTING TO BOOST MARKET GROWTH
  • 9.4 TOXICOGENOMICS
    TECHNOLOGICAL ADVANCEMENTS IN PROTEOMICS AND GENOMICS TO DRIVE MARKET
IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD
179
  • 10.1 INTRODUCTION
  • 10.2 CELLULAR ASSAYS
    DEVELOPMENT OF MULTIPARAMETER ASSAYS TO PROVIDE SIGNIFICANT GROWTH OPPORTUNITIES FOR MARKET PLAYERS
  • 10.3 BIOCHEMICAL ASSAYS
    HELP REFLECT UPON UNNATURAL CHANGES INDUCED BY TEST SUBSTANCES
  • 10.4 MOLECULAR TOXICOLOGY ASSAYS
    RISING INVESTMENTS IN MOLECULAR TOXICOLOGY TECHNOLOGIES TO DRIVE MARKET
  • 10.5 EX VIVO MODELS
    RISING DEMAND FOR ALTERNATIVES TO ANIMAL TESTING TO DRIVE MARKET
  • 10.6 IN SILICO MODELS
    HELP REDUCE NUMBER OF SAMPLES TESTED
IN VITRO TOXICOLOGY TESTING MARKET, BY REGION
196
  • 11.1 INTRODUCTION
  • 11.2 EUROPE
    GERMANY
    - Well-established pharmaceuticals industry to support market growth
    UK
    - Rising focus on research activities and academia-industry partnerships to drive market
    FRANCE
    - Increasing government funding for proteomics and genomics research to drive market
    ITALY
    - Increasing life sciences research to propel market
    SPAIN
    - Growing chemicals industry to support market growth
    REST OF EUROPE
    RECESSION IMPACT
  • 11.3 NORTH AMERICA
    US
    - Growing focus on biomarker discovery and research in structure-based drug design to propel market
    CANADA
    - Strong support to carry out R&D in pharmaceutical and proteomics fields to boost market growth
    RECESSION IMPACT
  • 11.4 ASIA PACIFIC
    CHINA
    - Increasing international pressure to ban animal testing methods to propel market
    JAPAN
    - Rising demand for technologically advanced research products to drive market
    INDIA
    - Growing focus of universities on avoiding use of animals to test cosmetic products to propel market
    SOUTH KOREA
    - Growing focus of government to increase pharmaceutical spending to propel market growth
    REST OF ASIA PACIFIC
    RECESSION IMPACT
  • 11.5 LATIN AMERICA
    BRAZIL
    - Adoption of non-animal testing methods to propel market
    MEXICO
    - Ban on animal testing for cosmetics to support market growth
    REST OF LATIN AMERICA
    RECESSION IMPACT
  • 11.6 MIDDLE EAST & AFRICA
    MIDDLE EAST
    - Growing focus on AI-based technologies for drug discovery to drive market
    AFRICA
    - Precision medicine initiatives to fuel market growth
    RECESSION IMPACT
COMPETITIVE LANDSCAPE
284
  • 12.1 OVERVIEW
  • 12.2 STRATEGIES ADOPTED BY KEY PLAYERS
  • 12.3 REVENUE SHARE ANALYSIS
  • 12.4 MARKET SHARE ANALYSIS
  • 12.5 COMPANY EVALUATION MATRIX
    STARS
    EMERGING LEADERS
    PERVASIVE PLAYERS
    PARTICIPANTS
    COMPANY FOOTPRINT
    - Product/Service footprint analysis
    - Regional footprint analysis
  • 12.6 STARTUP/SME EVALUATION MATRIX
    PROGRESSIVE COMPANIES
    STARTING BLOCKS
    RESPONSIVE COMPANIES
    DYNAMIC COMPANIES
    COMPETITIVE BENCHMARKING
  • 12.7 COMPETITIVE SCENARIO
COMPANY PROFILES
301
  • 13.1 MAJOR PLAYERS
    THERMO FISHER SCIENTIFIC INC.
    - Business overview
    - Products & services offered
    - Recent developments
    - MnM view
    AGILENT TECHNOLOGIES, INC.
    - Business overview
    - Products & services offered
    - Recent developments
    - MnM view
    MERCK KGAA
    - Business overview
    - Products & services offered
    - Recent developments
    - MnM view
    LABORATORY CORPORATION OF AMERICA HOLDINGS
    - Business overview
    - Products & services offered
    - Recent developments
    EUROFINS SCIENTIFIC
    - Business overview
    - Products & services offered
    - Recent developments
    CHARLES RIVER LABORATORIES
    - Business overview
    - Products & services offered
    - Recent developments
    SGS SA
    - Business overview
    - Products & services offered
    - Recent developments
    REVVITY
    - Business overview
    - Products & services offered
    - Recent developments
    BIO-RAD LABORATORIES, INC.
    - Business overview
    - Products & services offered
    - Recent developments
    LONZA
    - Business overview
    - Products & services offered
    - Recent developments
    EVOTEC SE
    - Business overview
    - Products & services offered
    - Recent developments
    CATALENT, INC.
    - Business overview
    - Products & services offered
    - Recent developments
    INTERTEK GROUP PLC
    - Business overview
    - Products & services offered
    INOTIV
    - Business overview
    - Products & services offered
    - Recent developments
    PROMEGA CORPORATION
    - Business overview
    - Products & services offered
    - Recent developments
  • 13.2 OTHER PLAYERS
    BIOIVT
    CREATIVE BIOLABS
    SHANGHAI MEDICILON INC.
    CREATIVE BIOARRAY
    ARAGEN LIFE SCIENCES LTD.
    ENZO BIOCHEM INC.
    MICROBAC LABORATORIES, INC.
    VIMTA LABS LTD.
    PACIFIC BIOLABS, INC.
    MB RESEARCH LABORATORIES
APPENDIX
404
  • 14.1 DISCUSSION GUIDE
  • 14.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
  • 14.3 CUSTOMIZATION OPTIONS
  • 14.4 RELATED REPORTS
  • 14.5 AUTHOR DETAILS
LIST OF TABLES
 
  • TABLE 1 GLOBAL INFLATION RATE PROJECTIONS, 2021–2028 (% GROWTH)
  • TABLE 2 US: HEALTH EXPENDITURE, 2019–2022 (USD MILLION)
  • TABLE 3 US: HEALTH EXPENDITURE, 2023–2030 (USD MILLION)
  • TABLE 4 IN VITRO TOXICOLOGY TESTING MARKET: IMPACT ANALYSIS
  • TABLE 5 CHEMICAL TOXICITY DATABASES
  • TABLE 6 AVERAGE SELLING PRICE OF IN VITRO TOXICOLOGY TESTING PRODUCTS, BY KEY PLAYER
  • TABLE 7 AVERAGE SELLING PRICE OF IN VITRO TOXICOLOGY TESTING PRODUCTS, BY REGION
  • TABLE 8 ECOSYSTEM FOR IN VITRO TOXICOLOGY TESTING MARKET
  • TABLE 9 IN VITRO TOXICOLOGY TESTING MARKET: DETAILED LIST OF CONFERENCES & EVENTS
  • TABLE 10 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 11 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 12 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 13 REST OF THE WORLD: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 14 IN VITRO TOXICOLOGY TESTING MARKET: REGULATORY SCENARIO
  • TABLE 15 PORTER’S FIVE FORCES ANALYSIS
  • TABLE 16 IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
  • TABLE 17 IN VITRO TOXICOLOGY TESTING CONSUMABLES MARKET, BY REGION, 2021–2028 (USD MILLION)
  • TABLE 18 EUROPE: IN VITRO TOXICOLOGY TESTING CONSUMABLES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 19 NORTH AMERICA: IN VITRO TOXICOLOGY TESTING CONSUMABLES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 20 ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING CONSUMABLES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 21 LATIN AMERICA: IN VITRO TOXICOLOGY TESTING CONSUMABLES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 22 MIDDLE EAST & AFRICA: IN VITRO TOXICOLOGY TESTING CONSUMABLES MARKET, BY REGION, 2021–2028 (USD MILLION)
  • TABLE 23 IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE, 2021–2028 (USD MILLION)
  • TABLE 24 IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY REGION, 2021–2028 (USD MILLION)
  • TABLE 25 EUROPE: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 26 NORTH AMERICA: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 27 ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 28 LATIN AMERICA: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 29 MIDDLE EAST & AFRICA: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY REGION, 2021–2028 (USD MILLION)
  • TABLE 30 BACTERIAL TOXICITY ASSAYS MARKET, BY REGION, 2021–2028 (USD MILLION)
  • TABLE 31 EUROPE: BACTERIAL TOXICITY ASSAYS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 32 NORTH AMERICA: BACTERIAL TOXICITY ASSAYS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 33 ASIA PACIFIC: BACTERIAL TOXICITY ASSAYS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 34 LATIN AMERICA: BACTERIAL TOXICITY ASSAYS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 35 MIDDLE EAST & AFRICA: BACTERIAL TOXICITY ASSAYS MARKET, BY REGION, 2021–2028 (USD MILLION)
  • TABLE 36 ENZYME TOXICITY ASSAYS MARKET, BY REGION, 2021–2028 (USD MILLION)
  • TABLE 37 EUROPE: ENZYME TOXICITY ASSAYS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 38 NORTH AMERICA: ENZYME TOXICITY ASSAYS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 39 ASIA PACIFIC: ENZYME TOXICITY ASSAYS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 40 LATIN AMERICA: ENZYME TOXICITY ASSAYS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 41 MIDDLE EAST & AFRICA: ENZYME TOXICITY ASSAYS MARKET, BY REGION, 2021–2028 (USD MILLION)
  • TABLE 42 CELL-BASED ELISA & WESTERN BLOTTING ASSAYS MARKET, BY REGION, 2021–2028 (USD MILLION)
  • TABLE 43 EUROPE: CELL-BASED ELISA & WESTERN BLOTTING ASSAYS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 44 NORTH AMERICA: CELL-BASED ELISA & WESTERN BLOTTING ASSAYS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 45 ASIA PACIFIC: CELL-BASED ELISA & WESTERN BLOTTING ASSAYS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 46 LATIN AMERICA: CELL-BASED ELISA & WESTERN BLOTTING ASSAYS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 47 MIDDLE EAST & AFRICA: CELL-BASED ELISA & WESTERN BLOTTING ASSAYS MARKET, BY REGION, 2021–2028 (USD MILLION)
  • TABLE 48 RECEPTOR-BINDING ASSAYS MARKET, BY REGION, 2021–2028 (USD MILLION)
  • TABLE 49 EUROPE: RECEPTOR-BINDING ASSAYS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 50 NORTH AMERICA: RECEPTOR-BINDING ASSAYS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 51 ASIA PACIFIC: RECEPTOR-BINDING ASSAYS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 52 LATIN AMERICA: RECEPTOR-BINDING ASSAYS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 53 MIDDLE EAST & AFRICA: RECEPTOR-BINDING ASSAYS MARKET, BY REGION, 2021–2028 (USD MILLION)
  • TABLE 54 TISSUE CULTURE ASSAYS MARKET, BY REGION, 2021–2028 (USD MILLION)
  • TABLE 55 EUROPE: TISSUE CULTURE ASSAYS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 56 NORTH AMERICA: TISSUE CULTURE ASSAYS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 57 ASIA PACIFIC: TISSUE CULTURE ASSAYS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 58 LATIN AMERICA: TISSUE CULTURE ASSAYS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 59 MIDDLE EAST & AFRICA: TISSUE CULTURE ASSAYS MARKET, BY REGION, 2021–2028 (USD MILLION)
  • TABLE 60 OTHER ASSAYS MARKET, BY REGION, 2021–2028 (USD MILLION)
  • TABLE 61 EUROPE: OTHER ASSAYS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 62 NORTH AMERICA: OTHER ASSAYS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 63 ASIA PACIFIC: OTHER ASSAYS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 64 LATIN AMERICA: OTHER ASSAYS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 65 MIDDLE EAST & AFRICA: OTHER ASSAYS MARKET, BY REGION, 2021–2028 (USD MILLION)
  • TABLE 66 IN VITRO TOXICOLOGY TESTING SERVICES MARKET, BY REGION, 2021–2028 (USD MILLION)
  • TABLE 67 EUROPE: IN VITRO TOXICOLOGY TESTING SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 68 NORTH AMERICA: IN VITRO TOXICOLOGY TESTING SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 69 ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 70 LATIN AMERICA: IN VITRO TOXICOLOGY TESTING SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 71 MIDDLE EAST & AFRICA: IN VITRO TOXICOLOGY TESTING SERVICES MARKET, BY REGION, 2021–2028 (USD MILLION)
  • TABLE 72 IN VITRO TOXICOLOGY TESTING EQUIPMENT MARKET, BY REGION, 2021–2028 (USD MILLION)
  • TABLE 73 EUROPE: IN VITRO TOXICOLOGY TESTING EQUIPMENT MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 74 NORTH AMERICA: IN VITRO TOXICOLOGY TESTING EQUIPMENT MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 75 ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING EQUIPMENT MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 76 LATIN AMERICA: IN VITRO TOXICOLOGY TESTING EQUIPMENT MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 77 MIDDLE EAST & AFRICA: IN VITRO TOXICOLOGY TESTING EQUIPMENT MARKET, BY REGION, 2021–2028 (USD MILLION)
  • TABLE 78 IN VITRO TOXICOLOGY TESTING SOFTWARE MARKET, BY REGION, 2021–2028 (USD MILLION)
  • TABLE 79 EUROPE: IN VITRO TOXICOLOGY TESTING SOFTWARE MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 80 NORTH AMERICA: IN VITRO TOXICOLOGY TESTING SOFTWARE MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 81 ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING SOFTWARE MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 82 LATIN AMERICA: IN VITRO TOXICOLOGY TESTING SOFTWARE MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 83 MIDDLE EAST & AFRICA: IN VITRO TOXICOLOGY TESTING SOFTWARE MARKET, BY REGION, 2021–2028 (USD MILLION)
  • TABLE 84 IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICITY ENDPOINT & TEST, 2021–2028 (USD MILLION)
  • TABLE 85 IN VITRO ADME TESTING MARKET, BY REGION, 2021–2028 (USD MILLION)
  • TABLE 86 EUROPE: IN VITRO ADME TESTING MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 87 NORTH AMERICA: IN VITRO ADME TESTING MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 88 ASIA PACIFIC: IN VITRO ADME TESTING MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 89 LATIN AMERICA: IN VITRO ADME TESTING MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 90 MIDDLE EAST & AFRICA: IN VITRO ADME TESTING MARKET, BY REGION, 2021–2028 (USD MILLION)
  • TABLE 91 IN VITRO GENOTOXICITY TESTING MARKET, BY REGION, 2021–2028 (USD MILLION)
  • TABLE 92 EUROPE: IN VITRO GENOTOXICITY TESTING MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 93 NORTH AMERICA: IN VITRO GENOTOXICITY TESTING MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 94 ASIA PACIFIC: IN VITRO GENOTOXICITY TESTING MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 95 LATIN AMERICA: IN VITRO GENOTOXICITY TESTING MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 96 MIDDLE EAST & AFRICA: IN VITRO GENOTOXICITY TESTING MARKET, BY REGION, 2021–2028 (USD MILLION)
  • TABLE 97 IN VITRO SKIN IRRITATION, CORROSION, & SENSITIZATION TESTING MARKET, BY REGION, 2021–2028 (USD MILLION)
  • TABLE 98 EUROPE: IN VITRO SKIN IRRITATION, CORROSION, & SENSITIZATION TESTING MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 99 NORTH AMERICA: IN VITRO SKIN IRRITATION, CORROSION, & SENSITIZATION TESTING MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 100 ASIA PACIFIC: IN VITRO SKIN IRRITATION, CORROSION, & SENSITIZATION TESTING MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 101 LATIN AMERICA: IN VITRO SKIN IRRITATION, CORROSION, & SENSITIZATION TESTING MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 102 MIDDLE EAST & AFRICA: IN VITRO SKIN IRRITATION, CORROSION, & SENSITIZATION TESTING MARKET, BY REGION, 2021–2028 (USD MILLION)
  • TABLE 103 IN VITRO CYTOTOXICITY TESTING MARKET, BY REGION, 2021–2028 (USD MILLION)
  • TABLE 104 EUROPE: IN VITRO CYTOTOXICITY TESTING MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 105 NORTH AMERICA: IN VITRO CYTOTOXICITY TESTING MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 106 ASIA PACIFIC: IN VITRO CYTOTOXICITY TESTING MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 107 LATIN AMERICA: IN VITRO CYTOTOXICITY TESTING MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 108 MIDDLE EAST & AFRICA: IN VITRO CYTOTOXICITY TESTING MARKET, BY REGION, 2021–2028 (USD MILLION)
  • TABLE 109 IN VITRO OCULAR TOXICITY TESTING MARKET, BY REGION, 2021–2028 (USD MILLION)
  • TABLE 110 EUROPE: IN VITRO OCULAR TOXICITY TESTING MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 111 NORTH AMERICA: IN VITRO OCULAR TOXICITY TESTING MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 112 ASIA PACIFIC: IN VITRO OCULAR TOXICITY TESTING MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 113 LATIN AMERICA: IN VITRO OCULAR TOXICITY TESTING MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 114 MIDDLE EAST & AFRICA: IN VITRO OCULAR TOXICITY TESTING MARKET, BY REGION, 2021–2028 (USD MILLION)
  • TABLE 115 IN VITRO ORGAN TOXICITY TESTING MARKET, BY REGION, 2021–2028 (USD MILLION)
  • TABLE 116 EUROPE: IN VITRO ORGAN TOXICITY TESTING MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 117 NORTH AMERICA: IN VITRO ORGAN TOXICITY TESTING MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 118 ASIA PACIFIC: IN VITRO ORGAN TOXICITY TESTING MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 119 LATIN AMERICA: IN VITRO ORGAN TOXICITY TESTING MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 120 MIDDLE EAST & AFRICA: IN VITRO ORGAN TOXICITY TESTING MARKET, BY REGION, 2021–2028 (USD MILLION)
  • TABLE 121 IN VITRO DERMAL TOXICITY TESTING MARKET, BY REGION, 2021–2028 (USD MILLION)
  • TABLE 122 EUROPE: IN VITRO DERMAL TOXICITY TESTING MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 123 NORTH AMERICA: IN VITRO DERMAL TOXICITY TESTING MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 124 ASIA PACIFIC: IN VITRO DERMAL TOXICITY TESTING MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 125 LATIN AMERICA: IN VITRO DERMAL TOXICITY TESTING MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 126 MIDDLE EAST & AFRICA: IN VITRO DERMAL TOXICITY TESTING MARKET, BY REGION, 2021–2028 (USD MILLION)
  • TABLE 127 IN VITRO PHOTOTOXICITY TESTING MARKET, BY REGION, 2021–2028 (USD MILLION)
  • TABLE 128 EUROPE: IN VITRO PHOTOTOXICITY TESTING MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 129 NORTH AMERICA: IN VITRO PHOTOTOXICITY TESTING MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 130 ASIA PACIFIC: IN VITRO PHOTOTOXICITY TESTING MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 131 LATIN AMERICA: IN VITRO PHOTOTOXICITY TESTING MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 132 MIDDLE EAST & AFRICA: IN VITRO PHOTOTOXICITY TESTING MARKET, BY REGION, 2021–2028 (USD MILLION)
  • TABLE 133 OTHER IN VITRO ENDPOINTS & TESTS MARKET, BY REGION, 2021–2028 (USD MILLION)
  • TABLE 134 EUROPE: OTHER IN VITRO ENDPOINTS & TESTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 135 NORTH AMERICA: OTHER IN VITRO ENDPOINTS & TESTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 136 ASIA PACIFIC: OTHER IN VITRO ENDPOINTS & TESTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 137 LATIN AMERICA: OTHER IN VITRO ENDPOINTS & TESTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 138 MIDDLE EAST & AFRICA: OTHER IN VITRO ENDPOINTS & TESTS MARKET, BY REGION, 2021–2028 (USD MILLION)
  • TABLE 139 IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY, 2021–2028 (USD MILLION)
  • TABLE 140 IN VITRO TOXICOLOGY TESTING MARKET FOR PHARMACEUTICAL & BIOPHARMACEUTICAL INDUSTRY, BY REGION, 2021–2028 (USD MILLION)
  • TABLE 141 EUROPE: IN VITRO TOXICOLOGY TESTING MARKET FOR PHARMACEUTICAL & BIOPHARMACEUTICAL INDUSTRY, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 142 NORTH AMERICA: IN VITRO TOXICOLOGY TESTING MARKET FOR PHARMACEUTICAL & BIOPHARMACEUTICAL INDUSTRY, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 143 ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING MARKET FOR PHARMACEUTICAL & BIOPHARMACEUTICAL INDUSTRY, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 144 LATIN AMERICA: IN VITRO TOXICOLOGY TESTING MARKET FOR PHARMACEUTICAL & BIOPHARMACEUTICAL INDUSTRY, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 145 MIDDLE EAST & AFRICA: IN VITRO TOXICOLOGY TESTING MARKET FOR PHARMACEUTICAL & BIOPHARMACEUTICAL INDUSTRY, BY REGION, 2021–2028 (USD MILLION)
  • TABLE 146 IN VITRO TOXICOLOGY TESTING MARKET FOR CONSUMER CARE INDUSTRY, BY REGION, 2021–2028 (USD MILLION)
  • TABLE 147 EUROPE: IN VITRO TOXICOLOGY TESTING MARKET FOR CONSUMER CARE INDUSTRY, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 148 NORTH AMERICA: IN VITRO TOXICOLOGY TESTING MARKET FOR CONSUMER CARE INDUSTRY, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 149 ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING MARKET FOR CONSUMER CARE INDUSTRY, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 150 LATIN AMERICA: IN VITRO TOXICOLOGY TESTING MARKET FOR CONSUMER CARE INDUSTRY, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 151 MIDDLE EAST & AFRICA: IN VITRO TOXICOLOGY TESTING MARKET FOR CONSUMER CARE INDUSTRY, BY REGION, 2021–2028 (USD MILLION)
  • TABLE 152 TYPES OF TOXICOLOGY TESTS FOR FOOD
  • TABLE 153 IN VITRO TOXICOLOGY TESTING MARKET FOR FOOD INDUSTRY, BY REGION, 2021–2028 (USD MILLION)
  • TABLE 154 EUROPE: IN VITRO TOXICOLOGY TESTING MARKET FOR FOOD INDUSTRY, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 155 NORTH AMERICA: IN VITRO TOXICOLOGY TESTING MARKET FOR FOOD INDUSTRY, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 156 ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING MARKET FOR FOOD INDUSTRY, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 157 LATIN AMERICA: IN VITRO TOXICOLOGY TESTING MARKET FOR FOOD INDUSTRY, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 158 MIDDLE EAST & AFRICA: IN VITRO TOXICOLOGY TESTING MARKET FOR FOOD INDUSTRY, BY REGION, 2021–2028 (USD MILLION)
  • TABLE 159 IN VITRO TOXICOLOGY TESTING MARKET FOR OTHER INDUSTRIES, BY REGION, 2021–2028 (USD MILLION)
  • TABLE 160 EUROPE: IN VITRO TOXICOLOGY TESTING MARKET FOR OTHER INDUSTRIES, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 161 NORTH AMERICA: IN VITRO TOXICOLOGY TESTING MARKET FOR OTHER INDUSTRIES, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 162 ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING MARKET FOR OTHER INDUSTRIES, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 163 LATIN AMERICA: IN VITRO TOXICOLOGY TESTING MARKET FOR OTHER INDUSTRIES, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 164 MIDDLE EAST & AFRICA: IN VITRO TOXICOLOGY TESTING MARKET FOR OTHER INDUSTRIES, BY REGION, 2021–2028 (USD MILLION)
  • TABLE 165 IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
  • TABLE 166 IN VITRO TOXICOLOGY TESTING MARKET FOR CELL CULTURE, BY REGION, 2021–2028 (USD MILLION)
  • TABLE 167 EUROPE: IN VITRO TOXICOLOGY TESTING MARKET FOR CELL CULTURE, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 168 NORTH AMERICA: IN VITRO TOXICOLOGY TESTING MARKET FOR CELL CULTURE, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 169 ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING MARKET FOR CELL CULTURE, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 170 LATIN AMERICA: IN VITRO TOXICOLOGY TESTING MARKET FOR CELL CULTURE, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 171 MIDDLE EAST & AFRICA: IN VITRO TOXICOLOGY TESTING MARKET FOR CELL CULTURE, BY REGION, 2021–2028 (USD MILLION)
  • TABLE 172 IN VITRO TOXICOLOGY TESTING MARKET FOR HIGH-THROUGHPUT SCREENING, BY REGION, 2021–2028 (USD MILLION)
  • TABLE 173 EUROPE: IN VITRO TOXICOLOGY TESTING MARKET FOR HIGH-THROUGHPUT SCREENING, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 174 NORTH AMERICA: IN VITRO TOXICOLOGY TESTING MARKET FOR HIGH-THROUGHPUT SCREENING, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 175 ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING MARKET FOR HIGH-THROUGHPUT SCREENING, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 176 LATIN AMERICA: IN VITRO TOXICOLOGY TESTING MARKET FOR HIGH-THROUGHPUT SCREENING, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 177 MIDDLE EAST & AFRICA: IN VITRO TOXICOLOGY TESTING MARKET FOR HIGH-THROUGHPUT SCREENING, BY REGION, 2021–2028 (USD MILLION)
  • TABLE 178 IN VITRO TOXICOLOGY TESTING MARKET FOR TOXICOGENOMICS, BY REGION, 2021–2028 (USD MILLION)
  • TABLE 179 EUROPE: IN VITRO TOXICOLOGY TESTING MARKET FOR TOXICOGENOMICS, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 180 NORTH AMERICA: IN VITRO TOXICOLOGY TESTING MARKET FOR TOXICOGENOMICS, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 181 ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING MARKET FOR TOXICOGENOMICS, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 182 LATIN AMERICA: IN VITRO TOXICOLOGY TESTING MARKET FOR TOXICOGENOMICS, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 183 MIDDLE EAST & AFRICA: IN VITRO TOXICOLOGY TESTING MARKET FOR TOXICOGENOMICS, BY REGION, 2021–2028 (USD MILLION)
  • TABLE 184 IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD, 2021–2028 (USD MILLION)
  • TABLE 185 IN VITRO TOXICOLOGY TESTING MARKET FOR CELLULAR ASSAYS, BY REGION, 2021–2028 (USD MILLION)
  • TABLE 186 EUROPE: IN VITRO TOXICOLOGY TESTING MARKET FOR CELLULAR ASSAYS, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 187 NORTH AMERICA: IN VITRO TOXICOLOGY TESTING MARKET FOR CELLULAR ASSAYS, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 188 ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING MARKET FOR CELLULAR ASSAYS, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 189 LATIN AMERICA: IN VITRO TOXICOLOGY TESTING MARKET FOR CELLULAR ASSAYS, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 190 MIDDLE EAST & AFRICA: IN VITRO TOXICOLOGY TESTING MARKET FOR CELLULAR ASSAYS, BY REGION, 2021–2028 (USD MILLION)
  • TABLE 191 IN VITRO TOXICOLOGY TESTING MARKET FOR BIOCHEMICAL ASSAYS, BY REGION, 2021–2028 (USD MILLION)
  • TABLE 192 EUROPE: IN VITRO TOXICOLOGY TESTING MARKET FOR BIOCHEMICAL ASSAYS, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 193 NORTH AMERICA: IN VITRO TOXICOLOGY TESTING MARKET FOR BIOCHEMICAL ASSAYS, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 194 ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING MARKET FOR BIOCHEMICAL ASSAYS, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 195 LATIN AMERICA: IN VITRO TOXICOLOGY TESTING MARKET FOR BIOCHEMICAL ASSAYS, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 196 MIDDLE EAST & AFRICA: IN VITRO TOXICOLOGY TESTING MARKET FOR BIOCHEMICAL ASSAYS, BY REGION, 2021–2028 (USD MILLION)
  • TABLE 197 IN VITRO TOXICOLOGY TESTING MARKET FOR MOLECULAR TOXICOLOGY ASSAYS, BY REGION, 2021–2028 (USD MILLION)
  • TABLE 198 EUROPE: IN VITRO TOXICOLOGY TESTING MARKET FOR MOLECULAR TOXICOLOGY ASSAYS, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 199 NORTH AMERICA: IN VITRO TOXICOLOGY TESTING MARKET FOR MOLECULAR TOXICOLOGY ASSAYS, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 200 ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING MARKET FOR MOLECULAR TOXICOLOGY ASSAYS, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 201 LATIN AMERICA: IN VITRO TOXICOLOGY TESTING MARKET FOR MOLECULAR TOXICOLOGY ASSAYS, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 202 MIDDLE EAST & AFRICA: IN VITRO TOXICOLOGY TESTING MARKET FOR MOLECULAR TOXICOLOGY ASSAYS, BY REGION, 2021–2028 (USD MILLION)
  • TABLE 203 IN VITRO TOXICOLOGY TESTING MARKET FOR EX VIVO MODELS, BY REGION, 2021–2028 (USD MILLION)
  • TABLE 204 EUROPE: IN VITRO TOXICOLOGY TESTING MARKET FOR EX VIVO MODELS, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 205 NORTH AMERICA: IN VITRO TOXICOLOGY TESTING MARKET FOR EX VIVO MODELS, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 206 ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING MARKET FOR EX VIVO MODELS, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 207 LATIN AMERICA: IN VITRO TOXICOLOGY TESTING MARKET FOR EX VIVO MODELS, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 208 MIDDLE EAST & AFRICA: IN VITRO TOXICOLOGY TESTING MARKET FOR EX VIVO MODELS, BY REGION, 2021–2028 (USD MILLION)
  • TABLE 209 IN VITRO TOXICOLOGY TESTING MARKET FOR IN SILICO MODELS, BY REGION, 2021–2028 (USD MILLION)
  • TABLE 210 EUROPE: IN VITRO TOXICOLOGY TESTING MARKET FOR IN SILICO MODELS, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 211 NORTH AMERICA: IN VITRO TOXICOLOGY TESTING MARKET FOR IN SILICO MODELS, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 212 ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING MARKET FOR IN SILICO MODELS, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 213 LATIN AMERICA: IN VITRO TOXICOLOGY TESTING MARKET FOR IN SILICO MODELS, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 214 MIDDLE EAST & AFRICA: IN VITRO TOXICOLOGY TESTING MARKET FOR IN SILICO MODELS, BY REGION, 2021–2028 (USD MILLION)
  • TABLE 215 IN VITRO TOXICOLOGY TESTING MARKET, BY REGION, 2021–2028 (USD MILLION)
  • TABLE 216 EUROPE: IN VITRO TOXICOLOGY TESTING MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 217 EUROPE: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
  • TABLE 218 EUROPE: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE, 2021–2028 (USD MILLION)
  • TABLE 219 EUROPE: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICOLOGY ENDPOINT & TEST, 2021–2028 (USD MILLION)
  • TABLE 220 EUROPE: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
  • TABLE 221 EUROPE: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY, 2021–2028 (USD MILLION)
  • TABLE 222 EUROPE: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD, 2021–2028 (USD MILLION)
  • TABLE 223 GERMANY: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
  • TABLE 224 GERMANY: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE, 2021–2028 (USD MILLION)
  • TABLE 225 GERMANY: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICOLOGY ENDPOINT & TEST, 2021–2028 (USD MILLION)
  • TABLE 226 GERMANY: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
  • TABLE 227 GERMANY: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY, 2021–2028 (USD MILLION)
  • TABLE 228 GERMANY: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD, 2021–2028 (USD MILLION)
  • TABLE 229 UK: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
  • TABLE 230 UK: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE, 2021–2028 (USD MILLION)
  • TABLE 231 UK: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICOLOGY ENDPOINT & TEST, 2021–2028 (USD MILLION)
  • TABLE 232 UK: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
  • TABLE 233 UK: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY, 2021–2028 (USD MILLION)
  • TABLE 234 UK: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD, 2021–2028 (USD MILLION)
  • TABLE 235 FRANCE: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
  • TABLE 236 FRANCE: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE, 2021–2028 (USD MILLION)
  • TABLE 237 FRANCE: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICOLOGY ENDPOINT & TEST, 2021–2028 (USD MILLION)
  • TABLE 238 FRANCE: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
  • TABLE 239 FRANCE: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY, 2021–2028 (USD MILLION)
  • TABLE 240 FRANCE: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD, 2021–2028 (USD MILLION)
  • TABLE 241 ITALY: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
  • TABLE 242 ITALY: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE, 2021–2028 (USD MILLION)
  • TABLE 243 ITALY: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICOLOGY ENDPOINT & TEST, 2021–2028 (USD MILLION)
  • TABLE 244 ITALY: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
  • TABLE 245 ITALY: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY, 2021–2028 (USD MILLION)
  • TABLE 246 ITALY: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD, 2021–2028 (USD MILLION)
  • TABLE 247 SPAIN: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
  • TABLE 248 SPAIN: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE, 2021–2028 (USD MILLION)
  • TABLE 249 SPAIN: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICOLOGY ENDPOINT & TEST, 2021–2028 (USD MILLION)
  • TABLE 250 SPAIN: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
  • TABLE 251 SPAIN: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY, 2021–2028 (USD MILLION)
  • TABLE 252 SPAIN: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD, 2021–2028 (USD MILLION)
  • TABLE 253 REST OF EUROPE: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
  • TABLE 254 REST OF EUROPE: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE, 2021–2028 (USD MILLION)
  • TABLE 255 REST OF EUROPE: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICOLOGY ENDPOINT & TEST, 2021–2028 (USD MILLION)
  • TABLE 256 REST OF EUROPE: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
  • TABLE 257 REST OF EUROPE: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY, 2021–2028 (USD MILLION)
  • TABLE 258 REST OF EUROPE: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD, 2021–2028 (USD MILLION)
  • TABLE 259 NORTH AMERICA: IN VITRO TOXICOLOGY TESTING MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 260 NORTH AMERICA: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
  • TABLE 261 NORTH AMERICA: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE, 2021–2028 (USD MILLION)
  • TABLE 262 NORTH AMERICA: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICOLOGY ENDPOINT & TEST, 2021–2028 (USD MILLION)
  • TABLE 263 NORTH AMERICA: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
  • TABLE 264 NORTH AMERICA: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY, 2021–2028 (USD MILLION)
  • TABLE 265 NORTH AMERICA: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD, 2021–2028 (USD MILLION)
  • TABLE 266 US: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
  • TABLE 267 US: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE, 2021–2028 (USD MILLION)
  • TABLE 268 US: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICOLOGY ENDPOINT & TEST, 2021–2028 (USD MILLION)
  • TABLE 269 US: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
  • TABLE 270 US: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY, 2021–2028 (USD MILLION)
  • TABLE 271 US: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD, 2021–2028 (USD MILLION)
  • TABLE 272 CANADA: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
  • TABLE 273 CANADA: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE, 2021–2028 (USD MILLION)
  • TABLE 274 CANADA: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICOLOGY ENDPOINT & TEST, 2021–2028 (USD MILLION)
  • TABLE 275 CANADA: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
  • TABLE 276 CANADA: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY, 2021–2028 (USD MILLION)
  • TABLE 277 CANADA: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD, 2021–2028 (USD MILLION)
  • TABLE 278 ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 279 ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
  • TABLE 280 ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE, 2021–2028 (USD MILLION)
  • TABLE 281 ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICOLOGY ENDPOINT & TEST, 2021–2028 (USD MILLION)
  • TABLE 282 ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
  • TABLE 283 ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY, 2021–2028 (USD MILLION)
  • TABLE 284 ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD, 2021–2028 (USD MILLION)
  • TABLE 285 CHINA: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
  • TABLE 286 CHINA: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE, 2021–2028 (USD MILLION)
  • TABLE 287 CHINA: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICOLOGY ENDPOINT & TEST, 2021–2028 (USD MILLION)
  • TABLE 288 CHINA: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
  • TABLE 289 CHINA: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY, 2021–2028 (USD MILLION)
  • TABLE 290 CHINA: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD, 2021–2028 (USD MILLION)
  • TABLE 291 JAPAN: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
  • TABLE 292 JAPAN: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE, 2021–2028 (USD MILLION)
  • TABLE 293 JAPAN: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICOLOGY ENDPOINT & TEST, 2021–2028 (USD MILLION)
  • TABLE 294 JAPAN: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
  • TABLE 295 JAPAN: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY, 2021–2028 (USD MILLION)
  • TABLE 296 JAPAN: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD, 2021–2028 (USD MILLION)
  • TABLE 297 INDIA: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
  • TABLE 298 INDIA: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE, 2021–2028 (USD MILLION)
  • TABLE 299 INDIA: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICOLOGY ENDPOINT & TEST, 2021–2028 (USD MILLION)
  • TABLE 300 INDIA: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
  • TABLE 301 INDIA: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY, 2021–2028 (USD MILLION)
  • TABLE 302 INDIA: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD, 2021–2028 (USD MILLION)
  • TABLE 303 SOUTH KOREA: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
  • TABLE 304 SOUTH KOREA: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE, 2021–2028 (USD MILLION)
  • TABLE 305 SOUTH KOREA: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICOLOGY ENDPOINT & TEST, 2021–2028 (USD MILLION)
  • TABLE 306 SOUTH KOREA: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
  • TABLE 307 SOUTH KOREA: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY, 2021–2028 (USD MILLION)
  • TABLE 308 SOUTH KOREA: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD, 2021–2028 (USD MILLION)
  • TABLE 309 REST OF ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
  • TABLE 310 REST OF ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE, 2021–2028 (USD MILLION)
  • TABLE 311 REST OF ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICOLOGY ENDPOINT & TEST, 2021–2028 (USD MILLION)
  • TABLE 312 REST OF ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
  • TABLE 313 REST OF ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY, 2021–2028 (USD MILLION)
  • TABLE 314 REST OF ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD, 2021–2028 (USD MILLION)
  • TABLE 315 LATIN AMERICA: IN VITRO TOXICOLOGY TESTING MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 316 LATIN AMERICA: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
  • TABLE 317 LATIN AMERICA: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE, 2021–2028 (USD MILLION)
  • TABLE 318 LATIN AMERICA: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICOLOGY ENDPOINT & TEST, 2021–2028 (USD MILLION)
  • TABLE 319 LATIN AMERICA: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
  • TABLE 320 LATIN AMERICA: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY, 2021–2028 (USD MILLION)
  • TABLE 321 LATIN AMERICA: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD, 2021–2028 (USD MILLION)
  • TABLE 322 BRAZIL: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
  • TABLE 323 BRAZIL: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE, 2021–2028 (USD MILLION)
  • TABLE 324 BRAZIL: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICOLOGY ENDPOINT & TEST, 2021–2028 (USD MILLION)
  • TABLE 325 BRAZIL: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
  • TABLE 326 BRAZIL: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY, 2021–2028 (USD MILLION)
  • TABLE 327 BRAZIL: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD, 2021–2028 (USD MILLION)
  • TABLE 328 MEXICO: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
  • TABLE 329 MEXICO: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE, 2021–2028 (USD MILLION)
  • TABLE 330 MEXICO: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICOLOGY ENDPOINT & TEST, 2021–2028 (USD MILLION)
  • TABLE 331 MEXICO: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
  • TABLE 332 MEXICO: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY, 2021–2028 (USD MILLION)
  • TABLE 333 MEXICO: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD, 2021–2028 (USD MILLION)
  • TABLE 334 REST OF LATIN AMERICA: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
  • TABLE 335 REST OF LATIN AMERICA: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE, 2021–2028 (USD MILLION)
  • TABLE 336 REST OF LATIN AMERICA: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICOLOGY ENDPOINT & TEST, 2021–2028 (USD MILLION)
  • TABLE 337 REST OF LATIN AMERICA: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
  • TABLE 338 REST OF LATIN AMERICA: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY, 2021–2028 (USD MILLION)
  • TABLE 339 REST OF LATIN AMERICA: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD, 2021–2028 (USD MILLION)
  • TABLE 340 MIDDLE EAST & AFRICA: IN VITRO TOXICOLOGY TESTING MARKET, BY REGION, 2021–2028 (USD MILLION)
  • TABLE 341 MIDDLE EAST & AFRICA: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
  • TABLE 342 MIDDLE EAST & AFRICA: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE, 2021–2028 (USD MILLION)
  • TABLE 343 MIDDLE EAST & AFRICA: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICOLOGY ENDPOINT & TEST, 2021–2028 (USD MILLION)
  • TABLE 344 MIDDLE EAST & AFRICA: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
  • TABLE 345 MIDDLE EAST & AFRICA: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY, 2021–2028 (USD MILLION)
  • TABLE 346 MIDDLE EAST & AFRICA: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD, 2021–2028 (USD MILLION)
  • TABLE 347 MIDDLE EAST: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
  • TABLE 348 MIDDLE EAST: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE, 2021–2028 (USD MILLION)
  • TABLE 349 MIDDLE EAST: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICOLOGY ENDPOINT & TEST, 2021–2028 (USD MILLION)
  • TABLE 350 MIDDLE EAST: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
  • TABLE 351 MIDDLE EAST: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY, 2021–2028 (USD MILLION)
  • TABLE 352 MIDDLE EAST: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD, 2021–2028 (USD MILLION)
  • TABLE 353 AFRICA: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
  • TABLE 354 AFRICA: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE, 2021–2028 (USD MILLION)
  • TABLE 355 AFRICA: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICOLOGY ENDPOINT & TEST, 2021–2028 (USD MILLION)
  • TABLE 356 AFRICA: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
  • TABLE 357 AFRICA: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY, 2021–2028 (USD MILLION)
  • TABLE 358 AFRICA: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD, 2021–2028 (USD MILLION)
  • TABLE 359 IN VITRO TOXICOLOGY TESTING MARKET: DEGREE OF COMPETITION
  • TABLE 360 OVERALL FOOTPRINT ANALYSIS OF COMPANIES (2022)
  • TABLE 361 PRODUCT/SERVICE FOOTPRINT ANALYSIS OF COMPANIES (2022)
  • TABLE 362 REGIONAL FOOTPRINT ANALYSIS OF COMPANIES (2022)
  • TABLE 363 IN VITRO TOXICOLOGY TESTING MARKET: DETAILED LIST OF KEY STARTUP/SME PLAYERS
  • TABLE 364 IN VITRO TOXICOLOGY TESTING MARKET: COMPETITIVE BENCHMARKING OF STARTUP/SME PLAYERS
  • TABLE 365 KEY PRODUCT/SERVICE LAUNCHES
  • TABLE 366 KEY DEALS
  • TABLE 367 OTHER KEY DEVELOPMENTS
  • TABLE 368 THERMO FISHER SCIENTIFIC INC.: BUSINESS OVERVIEW
  • TABLE 369 AGILENT TECHNOLOGIES, INC.: BUSINESS OVERVIEW
  • TABLE 370 MERCK KGAA: BUSINESS OVERVIEW
  • TABLE 371 LABORATORY CORPORATION OF AMERICA HOLDINGS: BUSINESS OVERVIEW
  • TABLE 372 EUROFINS SCIENTIFIC: BUSINESS OVERVIEW
  • TABLE 373 CHARLES RIVER LABORATORIES: BUSINESS OVERVIEW
  • TABLE 374 SGS SA: BUSINESS OVERVIEW
  • TABLE 375 REVVITY: BUSINESS OVERVIEW
  • TABLE 376 BIO-RAD LABORATORIES, INC.: BUSINESS OVERVIEW
  • TABLE 377 LONZA: BUSINESS OVERVIEW
  • TABLE 378 EVOTEC SE: BUSINESS OVERVIEW
  • TABLE 379 CATALENT, INC.: BUSINESS OVERVIEW
  • TABLE 380 INTERTEK GROUP PLC: BUSINESS OVERVIEW
  • TABLE 381 INOTIV: BUSINESS OVERVIEW
  • TABLE 382 PROMEGA CORPORATION: BUSINESS OVERVIEW
  • TABLE 383 BIOIVT: COMPANY OVERVIEW
  • TABLE 384 CREATIVE BIOLABS: COMPANY OVERVIEW
  • TABLE 385 SHANGHAI MEDICILON INC.: COMPANY OVERVIEW
  • TABLE 386 CREATIVE BIOARRAY: COMPANY OVERVIEW
  • TABLE 387 ARAGEN LIFE SCIENCES LTD.: COMPANY OVERVIEW
  • TABLE 388 ENZO BIOCHEM INC.: COMPANY OVERVIEW
  • TABLE 389 MICROBAC LABORATORIES, INC.: COMPANY OVERVIEW
  • TABLE 390 VIMTA LABS LTD.: COMPANY OVERVIEW
  • TABLE 391 PACIFIC BIOLABS, INC.: COMPANY OVERVIEW
  • TABLE 392 MB RESEARCH LABORATORIES: COMPANY OVERVIEW
LIST OF FIGURES
 
  • FIGURE 1 IN VITRO TOXICOLOGY TESTING MARKET SEGMENTATION
  • FIGURE 2 RESEARCH DESIGN
  • FIGURE 3 IN VITRO TOXICOLOGY TESTING MARKET: BREAKDOWN OF PRIMARIES
  • FIGURE 4 IN VITRO TOXICOLOGY TESTING: MARKET SIZE ESTIMATION (SUPPLY-SIDE ANALYSIS), 2022
  • FIGURE 5 MARKET SIZE ESTIMATION: APPROACH 1 (REVENUE SHARE ANALYSIS), 2022
  • FIGURE 6 ILLUSTRATIVE EXAMPLE OF THERMO FISHER SCIENTIFIC INC.: REVENUE SHARE ANALYSIS, 2022
  • FIGURE 7 MARKET VALIDATION FROM PRIMARY EXPERTS
  • FIGURE 8 MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH
  • FIGURE 9 IN VITRO TOXICOLOGY TESTING MARKET: CAGR PROJECTIONS
  • FIGURE 10 IN VITRO TOXICOLOGY TESTING MARKET: GROWTH ANALYSIS OF DRIVERS, RESTRAINTS, CHALLENGES, AND OPPORTUNITIES
  • FIGURE 11 DATA TRIANGULATION METHODOLOGY
  • FIGURE 12 IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2023 VS. 2028 (USD MILLION)
  • FIGURE 13 IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICITY ENDPOINT & TEST, 2023 VS. 2028 (USD MILLION)
  • FIGURE 14 IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2023 VS. 2028 (USD MILLION)
  • FIGURE 15 IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY, 2023 VS. 2028 (USD MILLION)
  • FIGURE 16 IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD, 2023 VS. 2028 (USD MILLION)
  • FIGURE 17 GEOGRAPHICAL SNAPSHOT OF IN VITRO TOXICOLOGY TESTING MARKET
  • FIGURE 18 PUBLIC RESISTANCE AGAINST ANIMAL TESTING TO DRIVE MARKET
  • FIGURE 19 CELLULAR ASSAYS ACCOUNTED FOR LARGEST SHARE OF ASIA PACIFIC IN VITRO TOXICOLOGY TESTING MARKET IN 2022
  • FIGURE 20 GERMANY TO REGISTER HIGHEST GROWTH DURING FORECAST PERIOD
  • FIGURE 21 CONSUMABLES ACCOUNTED FOR LARGEST MARKET SHARE IN 2022
  • FIGURE 22 IN VITRO TOXICOLOGY TESTING MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • FIGURE 23 HISTORY OF EU BAN ON ANIMAL TESTING FOR COSMETICS
  • FIGURE 24 INCREASE IN GLOBAL PHARMACEUTICAL R&D SPENDING, 2014–2028 (USD BILLION)
  • FIGURE 25 REVENUE SHIFT & NEW POCKETS FOR IN VITRO TOXICOLOGY TESTING PRODUCT/SERVICE PROVIDERS
  • FIGURE 26 VALUE CHAIN ANALYSIS: MAJOR VALUE ADDED DURING PRODUCT DEVELOPMENT AND MANUFACTURING PHASE
  • FIGURE 27 SUPPLY CHAIN ANALYSIS: IN VITRO TOXICOLOGY TESTING MARKET
  • FIGURE 28 ECOSYSTEM ANALYSIS: IN VITRO TOXICOLOGY TESTING MARKET
  • FIGURE 29 IN VITRO TOXICOLOGY TESTING MARKET: PATENTS GRANTED (JANUARY 2013–SEPTEMBER 2023)
  • FIGURE 30 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF IN VITRO TOXICOLOGY TESTING
  • FIGURE 31 KEY BUYING CRITERIA FOR END USERS
  • FIGURE 32 EUROPE: IN VITRO TOXICOLOGY TESTING MARKET SNAPSHOT
  • FIGURE 33 ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING MARKET SNAPSHOT
  • FIGURE 34 IN VITRO TOXICOLOGY TESTING MARKET: STRATEGIES ADOPTED BY KEY PLAYERS
  • FIGURE 35 REVENUE SHARE ANALYSIS OF TOP PLAYERS IN IN VITRO TOXICOLOGY TESTING MARKET, 2018–2022
  • FIGURE 36 IN VITRO TOXICOLOGY TESTING MARKET SHARE, BY KEY PLAYER, 2022
  • FIGURE 37 IN VITRO TOXICOLOGY TESTING MARKET: COMPANY EVALUATION MATRIX FOR KEY PLAYERS, 2022
  • FIGURE 38 IN VITRO TOXICOLOGY TESTING MARKET: COMPANY EVALUATION MATRIX FOR STARTUPS/SMES, 2022
  • FIGURE 39 THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT (2022)
  • FIGURE 40 AGILENT TECHNOLOGIES, INC.: COMPANY SNAPSHOT (2022)
  • FIGURE 41 MERCK KGAA: COMPANY SNAPSHOT (2022)
  • FIGURE 42 LABORATORY CORPORATION OF AMERICA HOLDINGS: COMPANY SNAPSHOT (2022)
  • FIGURE 43 EUROFINS SCIENTIFIC: COMPANY SNAPSHOT (2022)
  • FIGURE 44 CHARLES RIVER LABORATORIES: COMPANY SNAPSHOT (2022)
  • FIGURE 45 SGS SA: COMPANY SNAPSHOT (2022)
  • FIGURE 46 REVVITY: COMPANY SNAPSHOT (2022)
  • FIGURE 47 BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT (2022)
  • FIGURE 48 LONZA: COMPANY SNAPSHOT (2022)
  • FIGURE 49 EVOTEC SE: COMPANY SNAPSHOT (2022)
  • FIGURE 50 CATALENT, INC.: COMPANY SNAPSHOT (2022)
  • FIGURE 51 INTERTEK GROUP PLC: COMPANY SNAPSHOT (2022)
  • FIGURE 52 INOTIV: COMPANY SNAPSHOT (2022)

This research study involved the extensive use of secondary sources, directories, and databases to identify and collect valuable information for the analysis of the global in vitro toxicology testing market. In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, to obtain and verify critical qualitative and quantitative information and assess the growth prospects of the market. The global market size estimated through secondary research was then triangulated with inputs from primary research to arrive at the final market size.

Secondary Research

Secondary research was used mainly to identify and collect information for the extensive, technical, market-oriented, and commercial study of the In vitro toxicology testing market. The secondary sources used for this study include World Health Organization (WHO), Organisation for Economic Co-operation and Development (OECD), The Lens, American Society for Testing and Materials (ASTM), Center for Alternatives to Animal Testing (CAAT), European Union Reference Laboratory for Alternatives to Animal Testing (EURL ECVAM), National Institute of Environmental Health Sciences (NIEHS), Scientific Group on Methodologies for the Safety Evaluation of Chemicals (SGOMSEC), United States Environmental Protection Agency (USEPA), US Food and Drug Administration (US FDA), US Census Bureau, Eurostat, Statista, and Factiva. The Scientist Magazine, ScienceDirect, research journals, corporate filings such as annual reports, SEC filings, investor presentations, and financial statements, press releases, trade, business, professional associations and among others. These sources were also used to obtain key information about major players, market classification, and segmentation according to industry trends, regional/country-level markets, market developments, and technology perspectives.

Primary Research

Extensive primary research was conducted after acquiring basic knowledge about the global in vitro toxicology testing market scenario through secondary research. Several primary interviews were conducted with market experts from the demand side, such as pharmaceutical and biopharmaceutical companies, CROs, CMOs, and academic & research institutes, and experts from the supply side, such as C-level and D-level executives, product managers, marketing & sales managers of key manufacturers, distributors, and channel partners. These interviews were conducted across five major regions, including the Asia Pacific, North America, Europe, Latin America, and the Middle East & Africa. Approximately 70% and 30% of the primary interviews were conducted with supply-side and demand-side participants, respectively. This primary data was collected through questionnaires, e-mails, online surveys, personal interviews, and telephonic interviews.

The following is a breakdown of the primary respondents:

In Vitro Toxicology Testing Market Size, and Share

To know about the assumptions considered for the study, download the pdf brochure

Market Size Estimation

Both top-down and bottom-up approaches were used to estimate and validate the total size of the in vitro toxicology testing market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:

Bottom-up Approach

  • The key players in the industry and market have been identified through extensive secondary research.
  • The revenues generated from the In vitro toxicology testing business of leading players have been determined through primary and secondary research.
  • All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources.

In Vitro Toxicology Testing Market Size, and Share

To know about the assumptions considered for the study, Request for Free Sample Report

Top-down Approach

After arriving at the overall market size from the market size estimation process, the total market was split into several segments and subsegments.

In Vitro Toxicology Testing Market Size, and Share

Data Triangulation

To complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides.

Market Definition

Toxicology/Toxicity testing is required to evaluate compounds to identify their potential adverse effects to assure safety for human and environmental use. In vitro toxicology testing is ideally suited for the investigation of molecular, cellular, and physiological mechanisms of chemically induced toxicity, which cannot readily be studied in vivo. In vitro toxicology testing is widely used by pharmaceutical and biopharmaceutical, consumer care, food, and other industries.

Stakeholders

  • Academic Research Institutes
  • Biotechnology Companies
  • Pharmaceutical & Biopharmaceutical Companies
  • Chemical Companies
  • Medical Device Companies
  • Food & Beverage Manufacturers
  • Contract Research Organizations (CROs)
  • Market Research & Consulting Firms
  • Venture Capitalists & Investors
  • Government Associations

Report Objectives:

  • To define, describe, and forecast the global In vitro toxicology testing market based on the product & service, technology, toxicity endpoint & test, industry, method, and region.
  • To provide detailed information regarding the major factors influencing the growth of the market (such as drivers, restraints, opportunities, and challenges)
  • To strategically analyze micro-markets with respect to individual growth trends, future prospects, and contributions to the overall in vitro toxicology testing market
  • To analyze opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders.
  • To forecast the size of the market segments with respect to five main regions, namely, North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa
  • To strategically profile the key players and comprehensively analyze their product portfolios, market positions, and core competencies.
  • To track and analyze competitive developments such as acquisitions, agreements, collaborations, product launches, expansions, and R&D activities in the In vitro toxicology testing market.

Available Customizations

With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for this report:

Segment Analysis

  • Further breakdown of the other toxicity endpoint & test segments as per the product/service portfolios of prominent players operating in the market
  • Further breakdown of the other industries into chemical and medical devices industries.

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Geographical Analysis

  • Further breakdown of the Rest of European In vitro toxicology testing market into countries
  • Further breakdown of the Rest of Asia Pacific In vitro toxicology testing market into countries
  • Further breakdown of the Rest of Latin American In vitro toxicology testing market into countries

Previous Versions of this Report

In Vitro Toxicology Testing Market by Product (Assays (Western Blot, Tissue Culture), Equipment, Consumables, Software), Toxicity Endpoints (ADME, Skin Irritation, Cytotoxicity), Technology, Method, Industry (Pharma,Biotech) - Global Forecast to 2027

Report Code BT 2373
Published in Jun, 2022, By MarketsandMarkets™

In Vitro Toxicity Testing Market by Product (Assay (Western Blot, Tissue Culture),Equipment, Assay Reagent, Software), Toxicity Endpoints (ADME, Skin Irritation, Corrosion),Industry (Pharmaceutical, Cosmetics)-COVID-19 Impact - Global Forecast to 2025

Report Code BT 2373
Published in Aug, 2020, By MarketsandMarkets™

In-Vitro Toxicology/Toxicity Testing Market by Product & Services, Toxicity Endpoint & Test (Carcinogenicity, Dermal Toxicity), Technology (Cell-based, HTS), Method (Cellular Assays), Industry (Pharmaceutical, Cosmetics), Region-Global Forecast to 2024

Report Code BT 2373
Published in Sep, 2019, By MarketsandMarkets™

In Vitro Toxicology Testing Market by Products (Assays) & Services, Toxicity Endpoints & Tests (ADME, Skin, Genotoxicity, Organ Toxicity), Technology (Cell-based, HTS), Method (Cellular Assays, Ex-Vivo), Industry (Pharmaceutical, Cosmetics) - Forecast to 2022

Report Code BT 2373
Published in Sep, 2017, By MarketsandMarkets™

In Vitro Toxicology Testing Market by Product, Type (ADME), Toxicity Endpoints & Tests (Carcinogenicity, Dermal Toxicity, Genotoxicity), Technology (Genomics, Transcriptomics), Method (Cellular Assays), Industry (Pharmaceutical) - Global Forecast to 2021

Report Code BT 2373
Published in Jun, 2016, By MarketsandMarkets™

In-Vitro Toxicology Testing Market by Industry (Diagnostic, Pharmaceutical, Cosmetics, Chemical), Technology (Cell Culture, HTS, Omics), Applications (Systemic, Dermal, Ocular), Method (Cellular Assay, Ex vivo, In Silico) - Global Forecast to 2018

Report Code BT 2373
Published in Apr, 2014, By MarketsandMarkets™
"Our USP is "providing game-changing business opportunities reports with free customization" - so please feel free to provide us with your specific areas of interest / business challenges in much greater detail !!"

We appreciate your interest in this report. Once you fill out the form, you'll be immediately directed to an exclusive solution tailored to your needs. This high-value offering can help boost your revenue by 30% - a must-see opportunity for anyone looking to maximize growth.

By clicking the "Submit" button, you are agreeing to the Terms of Use and Privacy Policy.

Custom Market Research Services

We Will Customise The Research For You, In Case The Report Listed Above Does Not Meet With Your Requirements

Get 10% Free Customisation

Growth opportunities and latent adjacency in In Vitro Toxicology Testing Market

James

Oct, 2021

Thanks for this amazing information. keep posting it. .

Harrison

Oct, 2022

In what way the global In Vitro Toxicology Testing Market is impacted by the COVID19?.

©2025 Marketsandmarkets Research Private Ltd. All Rights Reserved.

DMCA.com Protection Status